| Catalogue number: |
D194920 |
| Chemical name: |
Darapladib |
| Synonyms: |
N-[2-(Diethylamino)ethyl]-2-[[(4-fluorophenyl)methyl]thio]-4,5,6,7-tetrahydro-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1H-cyclopentapyrimidine-1-acetamide; 1-[[[N-[2-(Diethylamino)ethyl]-N-[4-[4-(trifluoromethyl)phenyl]benzyl]amino]carbonyl]methyl]-2-(4-fluorobenzylthio)-5,6-trimethylenepyrimidin-4-one; SB 435445; SB 480848 |
| Impurity: |
|
| CAS Number: |
356057-34-6 |
| Possible CAS #: |
NA |
| Molecular form.: |
C??H??F?N?O?S |
| Appearance: |
No Data Available |
| Melting Point: |
No Data Available |
| Mol. Weight: |
666.77 |
| Storage: |
No Data Available |
| Solubility: |
No Data Available |
| Stability: |
No Data Available |
| Category: |
Amines, Aromatics, Heterocycles, Inhibitors, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds |
| Boiling Point: |
No Data Available |
| Applications: |
Darapladib (SB-480848) is a reversible lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor. |
| Dangerous Goods Info: |
NA |
| References: |
|
| |
|
| |
| Peer Review Product Citations: |
|
| |
| |
|
| |
|
|
| |
|
